Thesis (Ph.D. (Nutrition))--North-West University, Potchefstroom Campus, 2007.

Motivation: Cardiovascular heart disease (CVD) is the leading cause of death worldwide. Risk markers for CVD include, amongst others, the haemostatic factors tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor type 1 (PAI-1), factor VII (FVII) and fibrinogen and more recently, C-reactive protein (CRP), a sensitive marker of inflammation. Epidemiological studies have demonstrated an inverse association between dietary fibre (DF) consumption and risk factors for CVD and CVD prevalence. Some research indicates that this protection may be related to favourable changes in the haemostatic profile and inflammatory markers. This is applicable for the consumption of total DF, as well as soluble and insoluble fibre. However, clinical intervention trials report conflicting data on the effects of DF on t-PA, PAI-1, FVII, fibrinogen and CRP. In addition, available literature is not clear on the mechanisms through which DF may have favourable effects. Objective: The main objective of this study was to review the results of randomised controlled trials systematically on the effects of DF on the above-mentioned selected haemostatic variables and CRP in healthy adults and subjects with hypertriglyceridaemia and the metabolic syndrome. Methods: Human adult intervention trials, at least two weeks in duration, with an increased and measurable consumption of DF were included. Electronic databases were searched from the earliest record to May/July 2006 and supplemented by crosschecking reference lists of relevant publications. From the literature search, two reviewers identified studies that were rated for quality based on the published methodology. No formal statistical analysis was performed due to the large differences in the study designs of the dietary intervention trials. The primary outcome measures were percentage changes between intervention and control groups, or baseline to end comparisons for t-PA, PAI-1, FVII, fibrinogen and CRP. Results t-PA activity increased significantly (14-167%) over the short and long-term following increased fibre intakes. PAI-1 activity decreased significantly between 15-57% over periods ranging from two to six weeks. These favourable changes in t-PA and PAI-1 occurred in healthy, hypertriglyceridaemic and metabolic syndrome subjects following consumption of diets containing ≥3.3 g/MJ DF and ≥4.5 g/MJ DF respectively. Mechanisms through which DF may affect t-PA and PAI-1 include its lowering effect on insulinaemic and glycaemic responses, decreasing triglycerides which are a precursor of very-low-density lipoproteins, fermentation of DF to short-chain fatty acids, which may reduce free fatty acid concentrations, as well as the role of DF in promoting weight loss. High DF intakes did not have a significant effect on fibrinogen concentrations possibly because of relatively little weight loss, too low DF dosages and maintaining a good nutritional status. Inadequate study designs deterred from meaningful conclusions. Significant decreases in FVll coagulant activity (6-16%) were observed with DF intakes of ≥3.3 g/MJ and concomitant decreased saturated fat intakes and weight loss in healthy and hypertriglyceridaemic subjects. Confounding factors include weight loss and a simultaneous decreased intake of saturated fats. The type of fibre seems to play a role as well. Mechanisms through which DF may reduce FVll concentrations include its effects on triglyceride-rich lipoproteins, insulin and weight loss. Increased DF consumption with dosages ranging between 3.3-7.8 g/MJ were followed by significantly lower CRP concentrations (25-54%), however, simultaneous weight loss and altered fatty acid intakes were also present in all the studies. Mechanisms are inconclusive but may involve the effect of DF on weight loss, insulin, glucose, adiponectin, interleukin-6, free fatty acids and triglycerides. Conclusions: Epidemiological evidence indicates an association between DF and the CVD risk factors t-PA, PAI-1, FVII, fibrinogen and CRP. In general, the risk of CVD may improve with high-fibre intakes as indicated by the favourable changes in some of the parameters. However, simultaneous reduced fat intakes and weight loss presented difficulties in separating out the effects of specific components. Furthermore, DF is consumed in a variety of different forms and different dosages that may have different effects. Overall, the study designs used in the intervention trials prevented significant conclusions. DF did, however, play a role in modifying t-PA, PAI-1, FVII and CRP. Potential effects on fibrinogen were not quantifiable. Recommendations: The results from this investigation provide the motivation for additional controlled clinical research to establish the effect and mechanisms of DF on haemostatic variables and CRP. A critical aspect of future studies would be to set up suitable protocols. The amount of subjects, duration of the trials, confounding factors such as weight loss and altered fat intakes and differentiation between types and dosage of DF are important. DF supplemental studies are recommended as they may be the most suitable method to reach meaningful conclusions. / Thesis (Ph.D. (Nutrition))--North-West University, Potchefstroom Campus, 2007

Diss. (sammanfattning) Stockholm : Karol. inst., 2006. / Härtill 5 uppsatser.

No description available.

Thesis (MSc)--University of Stellenbosch, 2007. / ENGLISH ABSTRACT: This study describes: 1. The isolation and the purification of tissue type plasminogen activator and urokinase plasminogen activator in bovine milk. 2. The biochemical characterisation of tissue type plasminogen activator in bovine milk. 3. An investigation of the influence of the addition of purified tissue type plasminogen activator to ultra high temperature milk, Gouda cheese and yoghurt. / AFRIKAANSE OPSOMMING: Hierdie studie beskryf: 1. Die isolering en suiwering van weefseltipe-plasminogeenaktiveerder en urokinase-plasminogeenaktiveerder in beesmelk. 2. Die biochemiese karakterisering van weefseltipe-plasmingeenaktiveerder in beesmelk. 3. `n Ondersoek na die invloed van die byvoeging van gesuiwerde weefseltipe-plasminogeenaktiveerder by ultra hoë temperatuur melk, Gouda kaas en joghurt.

A leptospirose é uma zoonose causada por bactérias patogênicas do gênero Leptospira. A doença representa um grave problema de saúde pública nos países tropicais subdesenvolvidos. Mais de 500.000 casos graves de leptospirose são notificados a cada ano e a taxa de mortalidade excede 10% (World Health Organization, 1999). Os roedores são o principal reservatório urbano da doença, e eliminam leptospiras viáveis no meio ambiente ao longo de toda a vida. As bactérias entram no hospedeiro por abrasões na pele ou por membranas mucosas e rapidamente se espalham pelo organismo atingindo vários órgãos. A identificação de mecanismos de invasão e de evasão imune apresentados por leptospiras patogênicas é extremamente relevante e tem sido alvo de pesquisas recentes desenvolvidas por vários grupos. Nesse contexto, a caracterização funcional de proteínas de membrana externa de Leptospira, principais alvos de interação com moléculas do hospedeiro, é de grande importância. O Fator de Elongação Tu (EF-Tu), uma proteína bacteriana abundante envolvida na síntese protéica, pertence à categoria das proteínas conhecidas como \"moonlighting\". Tais moléculas possuem a capacidade de exercer mais de uma função e, normalmente, localizam-se em diferentes compartimentos da célula. Há relatos de que EF-Tu de agentes patogênicos possa atuar como um fator de virulência. No presente trabalho, demonstrou-se que EF-Tu de Leptospira está localizado na superfície da bactéria e possui funções adicionais, sendo receptor para moléculas presentes no plasma do hospedeiro. Tal proteína interage com vários componentes da matriz extracellular e também com plasminogênio, de maneira dosedependente. Resíduos de lisina são importantes para essa interação. Plasminogênio ligado a EF-Tu é convertido em sua forma ativa, plasmina, que, por sua vez, é capaz de clivar os substratos naturais C3b e fibrinogênio. EF-Tu de Leptospira também se liga a Fator H, principal regulador da via alternativa do sistema complemento, e este mantém sua atividade funcional ao agir como co-fator de Fator I na clivagem de C3b. O potencial imunoprotetor de EF-Tu em modelo animal foi avaliado, tendo em vista o alto grau de conservação da proteína em diferentes espécies de Leptospira. EF-Tu não conferiu proteção significativa e, portanto, não deve ser considerado como um candidato vacinal contra a leptospirose. Em suma, EF-Tu de Leptospira deve contribuir para o processo de invasão e evasão ao sistema imune inato do hospedeiro, inativando o sistema complemento. Tanto quanto é do nosso conhecimento, essa é a primeira descrição de uma proteína \"moonlighting\" em Leptospira. / Leptospirosis is a zoonosis caused by pathogenic bacteria from the genus Leptospira. The disease represents a serious public health problem in underdeveloped tropical countries. More than 500,000 cases of severe leptospirosis are reported each year, with mortality rates exceeding 10% (World Health Organization, 1999). Rodents are the main urban reservoir of the disease, shedding viable leptospires throughout their lives in the environment. Leptospires infect hosts through small abrasions in the skin or mucous membranes and they rapidly disseminate to target organs. The identification of invasion mechanisms and immune evasion strategies employed by pathogenic leptospires is of great relevance. In this context, functional characterization of leptospiral outer membrane proteins, which represent the main targets for interaction with host molecules, is extremely important. The elongation factor Tu (EF-Tu), an abundant bacterial protein involved in protein synthesis, has been shown to display moonlighting activities. Known to perform more than one function at different times or in different places, it is found in several subcellular locations in a single organism, and may serve as a virulence factor in a range of important human pathogens. In this work we demonstrate that Leptospira EF-Tu is surface-exposed and performs additional roles as a cell-surface receptor for host plasma proteins. It interacts with several extracellular matrix components and also binds plasminogen in a dose-dependent manner. Lysine residues are critical for this interaction. Bound plasminogen is converted to active plasmin, which, in turn, is able to cleave the natural substrates C3b and fibrinogen. Leptospira EF-Tu also acquires Factor H (FH), the main soluble regulator of the alternative pathway of the complement system. FH bound to immobilized EF-Tu displays cofactor activity, mediating C3b degradation by Factor I (FI). Given the wide distribution of EF-Tu among Leptospira species, its immunoprotective potential was evaluated in an animal model. EF-Tu was not able to afford significant immunoprotection, and might not be considered a vaccine candidate against leptospirosis. In conclusion, EF-Tu may contribute to leptospiral tissue invasion and complement inactivation. To our knowledge, this is the first description of a leptospiral protein exhibiting moonlighting activities.

A leptospirose é uma zoonose causada por bactérias patogênicas do gênero Leptospira. A doença representa um grave problema de saúde pública nos países tropicais subdesenvolvidos. Mais de 500.000 casos graves de leptospirose são notificados a cada ano e a taxa de mortalidade excede 10% (World Health Organization, 1999). Os roedores são o principal reservatório urbano da doença, e eliminam leptospiras viáveis no meio ambiente ao longo de toda a vida. As bactérias entram no hospedeiro por abrasões na pele ou por membranas mucosas e rapidamente se espalham pelo organismo atingindo vários órgãos. A identificação de mecanismos de invasão e de evasão imune apresentados por leptospiras patogênicas é extremamente relevante e tem sido alvo de pesquisas recentes desenvolvidas por vários grupos. Nesse contexto, a caracterização funcional de proteínas de membrana externa de Leptospira, principais alvos de interação com moléculas do hospedeiro, é de grande importância. O Fator de Elongação Tu (EF-Tu), uma proteína bacteriana abundante envolvida na síntese protéica, pertence à categoria das proteínas conhecidas como \"moonlighting\". Tais moléculas possuem a capacidade de exercer mais de uma função e, normalmente, localizam-se em diferentes compartimentos da célula. Há relatos de que EF-Tu de agentes patogênicos possa atuar como um fator de virulência. No presente trabalho, demonstrou-se que EF-Tu de Leptospira está localizado na superfície da bactéria e possui funções adicionais, sendo receptor para moléculas presentes no plasma do hospedeiro. Tal proteína interage com vários componentes da matriz extracellular e também com plasminogênio, de maneira dosedependente. Resíduos de lisina são importantes para essa interação. Plasminogênio ligado a EF-Tu é convertido em sua forma ativa, plasmina, que, por sua vez, é capaz de clivar os substratos naturais C3b e fibrinogênio. EF-Tu de Leptospira também se liga a Fator H, principal regulador da via alternativa do sistema complemento, e este mantém sua atividade funcional ao agir como co-fator de Fator I na clivagem de C3b. O potencial imunoprotetor de EF-Tu em modelo animal foi avaliado, tendo em vista o alto grau de conservação da proteína em diferentes espécies de Leptospira. EF-Tu não conferiu proteção significativa e, portanto, não deve ser considerado como um candidato vacinal contra a leptospirose. Em suma, EF-Tu de Leptospira deve contribuir para o processo de invasão e evasão ao sistema imune inato do hospedeiro, inativando o sistema complemento. Tanto quanto é do nosso conhecimento, essa é a primeira descrição de uma proteína \"moonlighting\" em Leptospira. / Leptospirosis is a zoonosis caused by pathogenic bacteria from the genus Leptospira. The disease represents a serious public health problem in underdeveloped tropical countries. More than 500,000 cases of severe leptospirosis are reported each year, with mortality rates exceeding 10% (World Health Organization, 1999). Rodents are the main urban reservoir of the disease, shedding viable leptospires throughout their lives in the environment. Leptospires infect hosts through small abrasions in the skin or mucous membranes and they rapidly disseminate to target organs. The identification of invasion mechanisms and immune evasion strategies employed by pathogenic leptospires is of great relevance. In this context, functional characterization of leptospiral outer membrane proteins, which represent the main targets for interaction with host molecules, is extremely important. The elongation factor Tu (EF-Tu), an abundant bacterial protein involved in protein synthesis, has been shown to display moonlighting activities. Known to perform more than one function at different times or in different places, it is found in several subcellular locations in a single organism, and may serve as a virulence factor in a range of important human pathogens. In this work we demonstrate that Leptospira EF-Tu is surface-exposed and performs additional roles as a cell-surface receptor for host plasma proteins. It interacts with several extracellular matrix components and also binds plasminogen in a dose-dependent manner. Lysine residues are critical for this interaction. Bound plasminogen is converted to active plasmin, which, in turn, is able to cleave the natural substrates C3b and fibrinogen. Leptospira EF-Tu also acquires Factor H (FH), the main soluble regulator of the alternative pathway of the complement system. FH bound to immobilized EF-Tu displays cofactor activity, mediating C3b degradation by Factor I (FI). Given the wide distribution of EF-Tu among Leptospira species, its immunoprotective potential was evaluated in an animal model. EF-Tu was not able to afford significant immunoprotection, and might not be considered a vaccine candidate against leptospirosis. In conclusion, EF-Tu may contribute to leptospiral tissue invasion and complement inactivation. To our knowledge, this is the first description of a leptospiral protein exhibiting moonlighting activities.

<p>Extracellular matrix degrading proteases from the plasminogen (plg) activator (PA) and the matrix metalloproteinase (MMP) systems have been implicated as important mediators of ovulation and corpus luteum (CL) formation and regression. The aim of this thesis was to investigate the expression and regulation of PAs and MMPs in the ovary and to examine their functional roles for CL formation and function. </p><p> The expression of membrane-type MMP-1 (MT1-MMP) and its substrate gelatinase A (MMP-2) mRNAs was studied during pregnant mare serum gonadotropin (PMSG)/human chorionic gonadotropin (hCG)-induced ovulation in immature rats. These proteases were coordinately regulated so that both were highly expressed in the theca cells of large preovulatory follicles. This suggests that MT1-MMP activates gelatinase A in preovulatory follicles to degrade the follicular wall during ovulation. </p><p> In pseudopregnant (psp) rats, MT1-MMP mRNA was expressed in the CL throughout the luteal phase. Tissue inhibitor of metalloproteases type-1 (TIMP-1) mRNA was expressed during CL formation and regression. MMP-2 and collagenase-3 mRNAs were expressed during CL formation and regression, respectively. When the luteal phase was artificially prolonged or shortened, TIMP-1 and collagenase-3 mRNAs were induced only after the serum progesterone levels had decreased, indicating a close association with luteolysis in the rat. </p><p> In psp mice, the expression of mRNAs coding for both PAs, seven MMPs, and five protease inhibitors was studied. Most of the studied molecules were coordinately expressed during formation or regression of the CL. However, uPA, MT1-MMP, and TIMP-3 mRNAs were expressed throughout the luteal phase. The role of uPA was examined in psp uPA deficient mice. These mice displayed no abnormalities in luteal function or vascularity. The role of uPA is thus either not essential or can be compensated by other proteases in the absence of uPA. </p><p> In order to control the timing of the CL formation, a mouse model for PMSG/hCG-induced CL formation was developed. Five different protocols were evaluated. One of them provided CL that were stable for six days. In that protocol the mice were treated with prolactin (PRL), twice daily from day 2 of CL life onward. The expression of the steroid acute regulatory protein (StAR) mRNA in the psp CL was also characterized to assess its use as a molecular marker for CL development and regression. It was highly expressed in the forming and functional CL and downregulated at a late stage of CL regression.</p><p> The functional role of plg and MMPs for CL formation and function was investigated in plg deficient mice treated with the MMP inhibitor galardin (GM6001). Both psp mice and PMSG/hCG +PRL-induced CL formation were used. Several molecular markers for CL development and regression were used to evaluate the health status of the CL. Our data showed that healthy and vascularized CL formed even in plg deficient mice treated with the inhibitor. However, serum progesterone levels were significantly reduced in these mice, an effect that was mainly attributable to the plg deficiency. In conclusion, neither plg nor MMPs, alone or in combination, seem to be essential for the development of a functional CL.</p>

Extracellular matrix degrading proteases from the plasminogen (plg) activator (PA) and the matrix metalloproteinase (MMP) systems have been implicated as important mediators of ovulation and corpus luteum (CL) formation and regression. The aim of this thesis was to investigate the expression and regulation of PAs and MMPs in the ovary and to examine their functional roles for CL formation and function. The expression of membrane-type MMP-1 (MT1-MMP) and its substrate gelatinase A (MMP-2) mRNAs was studied during pregnant mare serum gonadotropin (PMSG)/human chorionic gonadotropin (hCG)-induced ovulation in immature rats. These proteases were coordinately regulated so that both were highly expressed in the theca cells of large preovulatory follicles. This suggests that MT1-MMP activates gelatinase A in preovulatory follicles to degrade the follicular wall during ovulation. In pseudopregnant (psp) rats, MT1-MMP mRNA was expressed in the CL throughout the luteal phase. Tissue inhibitor of metalloproteases type-1 (TIMP-1) mRNA was expressed during CL formation and regression. MMP-2 and collagenase-3 mRNAs were expressed during CL formation and regression, respectively. When the luteal phase was artificially prolonged or shortened, TIMP-1 and collagenase-3 mRNAs were induced only after the serum progesterone levels had decreased, indicating a close association with luteolysis in the rat. In psp mice, the expression of mRNAs coding for both PAs, seven MMPs, and five protease inhibitors was studied. Most of the studied molecules were coordinately expressed during formation or regression of the CL. However, uPA, MT1-MMP, and TIMP-3 mRNAs were expressed throughout the luteal phase. The role of uPA was examined in psp uPA deficient mice. These mice displayed no abnormalities in luteal function or vascularity. The role of uPA is thus either not essential or can be compensated by other proteases in the absence of uPA. In order to control the timing of the CL formation, a mouse model for PMSG/hCG-induced CL formation was developed. Five different protocols were evaluated. One of them provided CL that were stable for six days. In that protocol the mice were treated with prolactin (PRL), twice daily from day 2 of CL life onward. The expression of the steroid acute regulatory protein (StAR) mRNA in the psp CL was also characterized to assess its use as a molecular marker for CL development and regression. It was highly expressed in the forming and functional CL and downregulated at a late stage of CL regression. The functional role of plg and MMPs for CL formation and function was investigated in plg deficient mice treated with the MMP inhibitor galardin (GM6001). Both psp mice and PMSG/hCG +PRL-induced CL formation were used. Several molecular markers for CL development and regression were used to evaluate the health status of the CL. Our data showed that healthy and vascularized CL formed even in plg deficient mice treated with the inhibitor. However, serum progesterone levels were significantly reduced in these mice, an effect that was mainly attributable to the plg deficiency. In conclusion, neither plg nor MMPs, alone or in combination, seem to be essential for the development of a functional CL.

No description available.